Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Giovanni Gabutti, Niccolò Bolognesi, Federica Sandri, Caterina Florescu & Armando Stefanati. (2019) Varicella zoster virus vaccines: an update. ImmunoTargets and Therapy 8, pages 15-28.
Read now
Read now
Helen Senderovich, Jasleen Grewal & Maheen Mujtaba. (2019) Herpes zoster vaccination efficacy in the long-term care facility population: a qualitative systematic review. Current Medical Research and Opinion 35:8, pages 1451-1462.
Read now
Read now
Federica Brosio, Giulia Masetti, Giulio Matteo, Armando Stefanati & Giovanni Gabutti. (2018) A novel nonlive, adjuvanted herpes zoster subunit vaccine: a report on the emerging clinical data and safety profile. Infection and Drug Resistance 11, pages 1401-1411.
Read now
Read now
Myron J. Levin, Eddy Bresnitz, Zoran Popmihajlov, Adriana Weinberg, Kai-Li Liaw, English Willis & Jeffrey R. Curtis. (2017) Studies with herpes zoster vaccines in immune compromised patients. Expert Review of Vaccines 16:12, pages 1217-1230.
Read now
Read now
Giovanni Gabutti, Paolo Bonanni, Michele Conversano, Guido Fanelli, Elisabetta Franco, Donato Greco, Giancarlo Icardi, Marzia Lazzari, Alessandro Rossi, Silvestro Scotti & Antonio Volpi. (2017) Prevention of Herpes Zoster and its complications: From clinical evidence to real life experience. Human Vaccines & Immunotherapeutics 13:2, pages 391-398.
Read now
Read now
Articles from other publishers (31)
Vincent Guiraud, Henri Thévenet & David Boutolleau. (2023) Detection of varicella zoster virus DNA in blood from immunocompromised patients during the week preceding the onset of herpes zoster rash. Journal of Clinical Virology 169, pages 105609.
Crossref
Crossref
Kazuhiro Matsumoto, Satoko Ohfuji, Kana Inohara, Masateru Akechi, Hiroko Kumashiro, Motoki Ishibashi, Shin Irie & Yoshio Hirota. (2023) Effectiveness of Live Attenuated Varicella-Zoster Vaccine in Adults Older than 50 Years in Japan: A Retrospective Cohort Study. Vaccines 11:2, pages 259.
Crossref
Crossref
Myron J. Levin. 2023. Plotkin's Vaccines. Plotkin's Vaccines
1334
1349.e7
.
Qiaoli Hua, Danwen Zheng, Bo Yu, Xinghua Tan, Qiumin Chen, Longde Wang, Jing Zhang, Yuntao Liu, Heng Weng, Yihang Cai, Xiaohua Xu, Bing Feng, Guangjuan Zheng, Banghan Ding, Jianwen Guo & Zhongde Zhang. (2022) Effectiveness of Inactivated COVID-19 Vaccines against COVID-19 Caused by the SARS-CoV-2 Delta and Omicron Variants: A Retrospective Cohort Study. Vaccines 10:10, pages 1753.
Crossref
Crossref
James F Mbinta, Binh P Nguyen, Prosper Mandela A Awuni, Janine Paynter & Colin R Simpson. (2022) Post-licensure zoster vaccine effectiveness against herpes zoster and postherpetic neuralgia in older adults: a systematic review and meta-analysis. The Lancet Healthy Longevity 3:4, pages e263-e275.
Crossref
Crossref
Khaled Seetan, Sharaf Albashir, Bashar Jarrar, Asem Aldebei, Murad Shatanawi, Hashem Abu Serhan & Sara Irshedat. (2021) Assessment of Serum Vitamin D Levels in the serum of Patients with Postherpetic neuralgia and its correlation to pain severity: A cross‐sectional comparative study. International Journal of Clinical Practice 75:11.
Crossref
Crossref
Mark G. ThompsonJefferey L. BurgessAllison L. NalewayHarmony TynerSarang K. YoonJennifer MeeceLauren E.W. OlshoAlberto J. Caban-Martinez, Ashley L. FowlkesKaren LutrickHolly C. GroomKayan DunniganMarilyn J. OdeanKurt HegmannElisha StefanskiLaura J. EdwardsNatasha Schaefer-SolleLauren GrantKatherine EllingsonJennifer L. KuntzTnelda ZunieMatthew S. ThieseLynn IvacicMeredith G. WesleyJulie Mayo LamberteXiaoxiao SunMichael E. SmithAndrew L. PhillipsKimberly D. GrooverYoung M. YooJoseph GeraldRachel T. BrownMeghan K. HerringGregory JosephShawn BeitelTyler C. MorrillJosephine MakPatrick RiversBrandon P. PoeBrian LynchYingtao ZhouJing ZhangAnna KelleherYan LiMonica DickersonErika HansonKyley GuentherSuxiang TongAllen BatemanErik ReisdorfJohn BarnesEduardo Azziz-BaumgartnerDanielle R. HuntMelissa L. ArvayPreeta KuttyAlicia M. FryManjusha Gaglani. (2021) Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines. New England Journal of Medicine 385:4, pages 320-329.
Crossref
Crossref
Jill M. Ferdinands, Mark G. Thompson, Lenee Blanton, Sarah Spencer, Lauren Grant & Alicia M. Fry. (2021) Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research. Vaccine 39:28, pages 3678-3695.
Crossref
Crossref
Lindsay Tjiattas-SaleskiDO, MBADO, MBA & Erik KruegerOMS-IIIOMS-III. (2021) Facial Rash with Eye Swelling. Osteopathic Family Physician, pages 44-46.
Crossref
Crossref
Moreno MenghiniVignesh RajaJeremy Raiter, Chandrakumar BalaratnasingamIan J. Constable. (2021) ACUTE RETINAL NECROSIS ASSOCIATED WITH HERPES ZOSTER VACCINATION. RETINAL Cases & Brief Reports 15:2, pages 166-168.
Crossref
Crossref
Jialing Lin, Timothy Dobbins, James G. Wood, Carla Bernardo, Nigel P. Stocks & Bette Liu. (2021) Effectiveness of the live-attenuated herpes zoster vaccine 2 years after its introduction in Australia. Vaccine 39:10, pages 1493-1498.
Crossref
Crossref
J. Gaillat. (2020) Zona. Revue des Maladies Respiratoires Actualités 12, pages A17-A20.
Crossref
Crossref
Jen-Yin Chen, Yao-Tsung Lin, Li-Kai Wang, Kuo-Chuan Hung, Kuo-Mao Lan, Chung-Han Ho & Chia-Yu Chang. (2019) Hypovitaminosis Din Postherpetic Neuralgia—High Prevalence and Inverse Association with Pain: A Retrospective Study. Nutrients 11:11, pages 2787.
Crossref
Crossref
Katia J. Bruxvoort, Anna S. Liang, Rafael Harpaz, Lei Qian, Lina S. Sy, Philip LaRussa, D. Scott Schmid, Yi Luo, Harpreet Takhar & Hung Fu Tseng. (2019) Patient report of herpes zoster pain: Incremental benefits of zoster vaccine live. Vaccine 37:26, pages 3478-3484.
Crossref
Crossref
Kaatje Bollaerts, Maria Alexandridou & Thomas Verstraeten. (2019) Risk factors for modified vaccine effectiveness of the live attenuated zoster vaccine among the elderly in England. Vaccine: X 1, pages 100007.
Crossref
Crossref
Anne Monette & Andrew J. Mouland. 2019. Biology of T Cells - Part B. Biology of T Cells - Part B
175
263
.
Pieter T. de Boer, Alies van Lier, Hester de Melker, Albert J. M. van Wijck, Jan C. Wilschut, Albert Jan van Hoek & Maarten J. Postma. (2018) Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines. BMC Medicine 16:1.
Crossref
Crossref
Andrea C Tricco, Wasifa Zarin, Roberta Cardoso, Areti-Angeliki Veroniki, Paul A Khan, Vera Nincic, Marco Ghassemi, Rachel Warren, Jane P Sharpe, Andrea V Page & Sharon E Straus. (2018) Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis. BMJ, pages k4029.
Crossref
Crossref
Jemma L. Walker, Nick J. Andrews, Gayatri Amirthalingam, Harriet Forbes, Sinead M. Langan & Sara L. Thomas. (2018) Effectiveness of herpes zoster vaccination in an older United Kingdom population. Vaccine 36:17, pages 2371-2377.
Crossref
Crossref
Myron J. Levin. 2018. Plotkin's Vaccines. Plotkin's Vaccines
1268
1281.e6
.
English D. Willis, Meredith Woodward, Elizabeth Brown, Zoran Popmihajlov, Patricia Saddier, Paula W. Annunziato, Neal A. Halsey & Anne A. Gershon. (2017) Herpes zoster vaccine live: A 10 year review of post-marketing safety experience. Vaccine 35:52, pages 7231-7239.
Crossref
Crossref
Nathaniel Erskine, Hoang Tran, Leonard Levin, Christine Ulbricht, Joyce Fingeroth, Catarina Kiefe, Robert J. Goldberg & Sonal Singh. (2017) A systematic review and meta-analysis on herpes zoster and the risk of cardiac and cerebrovascular events. PLOS ONE 12:7, pages e0181565.
Crossref
Crossref
Hector S. Izurieta, Michael Wernecke, Jeffrey Kelman, Sarah Wong, Richard Forshee, Douglas Pratt, Yun Lu, Qin Sun, Christopher Jankosky, Philip Krause, Chris Worrall, Tom MaCurdy & Rafael Harpaz. (2017) Effectiveness and Duration of Protection Provided by the Live-attenuated Herpes Zoster Vaccine in the Medicare Population Ages 65 Years and Older. Clinical Infectious Diseases 64:6, pages 785-793.
Crossref
Crossref
Michael N. Oxman & Ruth Harbecke. 2017. Herpes Zoster: Postherpetic Neuralgia and Other Complications. Herpes Zoster: Postherpetic Neuralgia and Other Complications
365
418
.
Giovanni Gabutti, Nicoletta Valente, Parvanè Kuhdari, Silvia Lupi & Armando Stefanati. (2016) Prevention of herpes zoster and its complications: from the clinic to the real-life experience with the vaccine. Journal of Medical Microbiology 65:12, pages 1363-1369.
Crossref
Crossref
Filippo Ansaldi, Cecilia Trucchi, Cristiano Alicino, Chiara Paganino, Andrea Orsi & Giancarlo Icardi. (2016) Real-World Effectiveness and Safety of a Live-Attenuated Herpes Zoster Vaccine: A Comprehensive Review. Advances in Therapy 33:7, pages 1094-1104.
Crossref
Crossref
Craig M. Hales, Rafael Harpaz & Stephanie R. Bialek. (2016) Self-reported herpes zoster, pain, and health care seeking in the Health and Retirement Study: implications for interpretation of health care?based studies. Annals of Epidemiology 26:6, pages 441-446.e3.
Crossref
Crossref
Gillian M. Keating. (2016) Shingles (Herpes Zoster) Vaccine (Zostavax®): A Review in the Prevention of Herpes Zoster and Postherpetic Neuralgia. BioDrugs 30:3, pages 243-254.
Crossref
Crossref
Mona Marin, Rafael Harpaz, John Zhang, Peter C. Wollan, Stephanie R. Bialek & Barbara P. Yawn. (2016) Risk Factors for Herpes Zoster Among Adults. Open Forum Infectious Diseases 3:3.
Crossref
Crossref
Nabila Ferahta, Imene Achek, Julie Dubourg & Pierre-Olivier Lang. (2016) Les vaccins contre le zona : efficacité, sécurité, et rapport coût/bénéfices. La Presse Médicale 45:2, pages 162-176.
Crossref
Crossref
Barbara P. Yawn, Peter C. Wollan, Maria A. Nagel & Don Gilden. (2016) Risk of Stroke and Myocardial Infarction After Herpes Zoster in Older Adults in a US Community Population. Mayo Clinic Proceedings 91:1, pages 33-44.
Crossref
Crossref